Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 19, 2015 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter 2014 Financial Results

SOLANA BEACH, Calif., Feb. 19, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
February 02, 2015 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Outlines Progress on Clinical Program

SOLANA BEACH, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today provided an...
December 02, 2014 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma's EVK-001 Showed No QT Prolongation in Thorough ECG (TQT) Study

SOLANA BEACH, Calif., Dec. 2, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
November 25, 2014 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma to Present at LD Micro Conference

SOLANA BEACH, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, will host an...
November 13, 2014 16:05 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Third Quarter 2014 Results

SOLANA BEACH, Calif., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
November 06, 2014 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results

SOLANA BEACH, Calif., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
September 09, 2014 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Announces the Completion of Enrollment in Its Thorough ECG Study for EVK-001

SOLANA BEACH, Calif., Sept. 9, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
September 04, 2014 08:30 ET | Source: Evoke Pharma, Inc.

Evoke Pharma to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference

SOLANA BEACH, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
August 13, 2014 16:01 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Second Quarter 2014 Results

SOLANA BEACH, Calif., Aug. 13, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
August 12, 2014 16:15 ET | Source: Evoke Pharma, Inc.

Evoke Pharma Announces Initiation of a Thorough ECG (QT) Study for EVK-001

SOLANA BEACH, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...